Investor · San Mateo, CA

Fred A. Middleton

Open Fred in the network graph →

Filings

15

SEC Form D

Connections

105

co-filers

Capital

$36.4M

across filings

Active

Mar 2010

to Feb 2023

Most-connected co-filers (105)

Peter C. Mcwilliams · San Mateo, CA8 shared David F. Ferrero · Boston, MA4 shared John Lewis · N/A, Hong Kong2 shared David T. Schiff · Carlsbad, CA2 shared Masaji Matsuoka · San Mateo, CA2 shared L. J. Cross · New York, NY2 shared Neil Shah · GREENWICH, CT2 shared Kevin B. Bacon · San Diego, CA2 shared Bruce J. Beal · New York, NY2 shared Harrison T. Lefrak · Carlsbad, CA2 shared Martin R. Laidlaw · Grand Cayman, Cayman Islands2 shared Marcos Horie · Sao Paulo, Guernsey2 shared Michael S. Paul · Salt Lake City, UT2 shared Peter S. Rhode · Miramar, FL1 shared Hing C. Wong · Miramar, FL1 shared Joe Kiani · Irvine, CA1 shared Michael W. Sherman · Minnetonka, MN1 shared Barak C. Bussel · Carlsbad, CA1 shared Howard Rochestie · Santa Barbara, CA1 shared Jeffrey M. Katz · Chicago, IL1 shared Mitchell C. Finer · Auburndale, MA1 shared Robert Mcneil · San Mateo, CA1 shared Mike Jerstad · Sioux Falls, SD1 shared Kenneth P. Arnold · Mountain View, CA1 shared

Recent filings (15)

Theravida, Inc.Feb 2023 · 5 co-filers$200K Theravida, Inc.Feb 2023 · 5 co-filers$200K HCW Biologics Inc.Oct 2020 · 11 co-filers$16.0M HCW Biologics Inc.Oct 2020 · 11 co-filers$16.0M CHIMERIX INCJul 2019 · 17 co-filers$34.9M CHIMERIX INCJul 2019 · 17 co-filers$34.9M Actimis Pharmaceuticals IncJun 2017 · 7 co-filers$1.0M Actimis Pharmaceuticals IncJun 2017 · 7 co-filers$1.0M Stereotaxis, Inc.Oct 2016 · 36 co-filers$24.0M AXIKIN PHARMACEUTICALS INCSep 2015 · 7 co-filers$11.6M LineaGen, IncJan 2015 · 20 co-filers$12.2M Explora Fund, SPC, on behalf of its Explora Brazil Long Only Segregated PortfolioMar 2014 · 5 co-filers Explora Fund, SPC, on behalf of its Equity Long Short Segregated PortfolioMar 2014 · 5 co-filers AXIKIN PHARMACEUTICALS INCMar 2014 · 7 co-filers$6.6M Explora Fund, SPC, on behalf of its Explora Brazil Long Only Segregated PortfolioAug 2013 · 2 co-filers Explora Fund, SPC, on behalf of its Equity Long Short Segregated PortfolioAug 2013 · 2 co-filers Sanderling Ventures VII, L.P.Jan 2013 · 8 co-filers$250.0M Sanderling Ventures VII, L.P.Jan 2013 · 8 co-filers$250.0M LineaGen IncJun 2010 · 14 co-filers$3.5M LineaGen IncJun 2010 · 14 co-filers$3.5M NOVOCELL, INCMar 2010 · 15 co-filers$2.0M NOVOCELL, INCMar 2010 · 15 co-filers$2.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Fred in the interactive graph →